Vasoactive Effects of IQP-AS-118 in Healthy Individuals
NCT02871310 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2020-02-12
Summary
The main objective of this study is to evaluate the benefit of IQP-AS-118 on the vasoactive effects in healthy subjects.
Conditions
- Blood Flow
- Cardiovascular Disease
Interventions
- DIETARY_SUPPLEMENT
-
IQP-AS-118
1 tablet in the morning
- DIETARY_SUPPLEMENT
-
Placebo
1 tablet in the morning
Sponsors & Collaborators
-
InQpharm Group
lead INDUSTRY
Principal Investigators
-
Ralf Uebelhack · analyze & realize GmbH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 45 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-03-31
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Effect of Apple Flavanols on Risk of Cardiovascular Disease
NCT00568152 ·Status: COMPLETED ·Phase: NA
-
Study of Artery Conditions of 'At-risk' Asian People Not on Lipid-lowering Drugs
NCT00970918 ·Status: COMPLETED ·Phase: NA
-
Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease
NCT06541691 ·Status: RECRUITING ·Phase: NA
-
Study to Investigate Safety and Tolerability of a Single Dose of AZD6482
NCT00688714 ·Status: COMPLETED ·Phase: PHASE1
-
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069 ·Status: RECRUITING ·Phase: PHASE4
-
The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)
NCT00906035 ·Status: TERMINATED ·Phase: NA
-
Study to Learn More About the Safety and Effectiveness of Rivaroxaban (Xarelto) When Given Together With Acetylsalicylic Acid to Indian People With Narrowing of the Arteries of the Heart (CAD) and/or With Reduced Blood Flow in the Arteries of the Legs and Arms With Symptoms (Symptomatic PAD)
NCT04298567 ·Status: COMPLETED
-
Reversal of the Anti-platelet Effects of Ticagrelor
NCT02383771 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension
NCT00105209 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease
NCT04308551 ·Status: WITHDRAWN ·Phase: NA
-
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
NCT00189618 ·Status: COMPLETED ·Phase: PHASE4
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
NSAIDs in Coronary Artery Disease Patients
NCT01402804 ·Status: COMPLETED
-
Aspirin and Plavix Following Coronary Artery Bypass Grafting
NCT01158703 ·Status: TERMINATED ·Phase: PHASE4
-
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
NCT03005704 ·Status: UNKNOWN ·Phase: NA
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
Acute Effect of Nitrate From Natural Dietary Sources on Arterial Stiffness and Blood Pressures in Healthy Individuals
NCT01604993 ·Status: COMPLETED ·Phase: PHASE2
-
Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction
NCT05310968 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs
NCT04401761 ·Status: COMPLETED
-
Personalizing Aspirin Therapy in Peripheral Arterial Disease Patients
NCT04269863 ·Status: UNKNOWN ·Phase: NA
-
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485 ·Status: COMPLETED ·Phase: NA
-
Assessment of Quitting Versus Using Aspirin Therapy In Patients Treated With Oral Anticoagulation for Atrial Fibrillation or Other Indication With Stabilized Coronary Artery Disease
NCT04217447 ·Status: TERMINATED ·Phase: PHASE3
-
Aspirin Dose and Atherosclerosis in Patients With Heart Disease
NCT00272337 ·Status: COMPLETED ·Phase: PHASE4